The global custom antibody market size was valued at USD 175.70 million in 2023 and is predicted to reach around USD 444.66 million by 2033, expanding at a CAGR of 9.73% from 2024 to 2033.
The custom antibody market involves the production of antibodies tailored to specific research or diagnostic needs. These antibodies are designed to bind to unique antigens, supporting various applications in biotechnology, pharmaceuticals, and research laboratories.
Get a Sample: https://www.precedenceresearch.com/sample/4562
Growth Factors:
Key growth factors driving the custom antibody market include increasing R&D activities in life sciences, rising demand for personalized medicine, and advancements in biotechnology. Additionally, the expanding applications of antibodies in diagnostics and therapeutics are fueling market growth.
Region Insights:
North America dominates the custom antibody market due to a robust biopharmaceutical sector, significant R&D investments, and a strong presence of biotechnology companies. Europe follows, driven by technological advancements and increasing healthcare expenditure. Asia-Pacific is witnessing rapid growth, propelled by expanding biotechnology and pharmaceutical industries.
Custom Antibody Market Scope
| Report Coverage | Details |
| Market Size by 2033 | USD 444.66 Million |
| Market Size in 2023 | USD 175.70 Million |
| Market Size in 2024 | USD 192.80 Million |
| Market Growth Rate from 2024 to 2033 | CAGR of 9.73% |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Type, Service, Source, Application, End-use, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Custom Antibody Market Dynamics
Drivers:
Drivers of the custom antibody market include growing adoption of monoclonal antibodies in therapeutics, rising prevalence of chronic diseases, and increasing focus on proteomics research. Moreover, advancements in hybridoma and recombinant DNA technology are enhancing antibody production capabilities.
Opportunities:
Opportunities in the custom antibody market include the development of novel antibody technologies, expanding applications in personalized medicine, and rising demand for antibodies in diagnostic assays. Additionally, collaborations between academic institutions and biotechnology firms present avenues for market expansion.
Challenges:
Challenges facing the custom antibody market include high development costs, stringent regulatory requirements, and complexities associated with antibody specificity and production scalability. Ensuring consistency and quality in antibody production also remains a challenge for manufacturers.
Read Also: Benzenoid Market Size to Reach USD 1,417.40 Million by 2033
Custom Antibody Market Companies
- GenScript
- LifeSpan BioSciences, Inc
- Labcorp Drug Development
- Abmart
- YenZym Antibodies, LLC.
- Kaneka Eurogentec S.A.
- Bio-Rad Laboratories, Inc
- Abcam plc
- Creative Diagnostics
- Thermo Fisher Scientific Inc.
Recent Developments
- In October 2022, Absolute Biotech Company launched to offer antibody reagents, services, and expertise to researchers worldwide for therapeutic, diagnostic, and research applications. The company offers recombinant antibody expression, antibody engineering, custom antibody sequencing services, and more than one million off-the-shelf life science reagents.
- In March 2024, a leading biotechnology company in genetic medicine, Agathos Biologics, launched its rAAV (recombinant adeno-associated virus) production service by using the company’s new AE1-BHK cell line. The company recorded its first sale of rAAV to a CRO/CMO (contract research and manufacturing organization), Genovac, that discovers, manufactures, and develops antibodies for research, therapeutics, and diagnostics market segments.
Segments Covered in the Report
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
By Service
- Antibody Development
- Antibody Production & Purification
- Antibody Fragmentation & Labeling
By Source
- Mice
- Rabbit
- Others
By Application
- Oncology
- Infectious Diseases
- Neurology
- Stem Cells
- Immunology
- Cardiovascular Diseases
- Others
By End-use
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CRO
- Hospitals and Clinics
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/
